Literature DB >> 11595825

Successful treatment of non-segmental vitiligo: systemic therapy with sex hormone-thyroid powder mixture.

K Nagai1, M Ichimiya, K Yokoyama, Y Hamamoto, M Muto.   

Abstract

We previously reported a patient with generalized vitiligo improved by oral administration of the drug for menopausal syndrome (sex hormone-thyroid powder mixture). In this study, we reevaluated the efficiency of this drug for vitiligo, and examined its pharmacological action in melanogenesis. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11595825     DOI: 10.1159/000053279

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Cancer Risks in Vitiligo Patients: A Nationwide Population-Based Study in Taiwan.

Authors:  Cheng-Yuan Li; Ying-Xiu Dai; Yi-Ju Chen; Szu-Ying Chu; Tzeng-Ji Chen; Chen-Yi Wu; Chih-Chiang Chen; Ding-Dar Lee; Yun-Ting Chang
Journal:  Int J Environ Res Public Health       Date:  2018-08-27       Impact factor: 3.390

2.  Urinary metabolomic investigations in vitiligo patients.

Authors:  Wei Liu; Xiao-Yan Liu; Yue-Tong Qian; Dong-Dong Zhou; Jia-Wei Liu; Tian Chen; Wei Sun; Dong-Lai Ma
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.